Kits Eyecare (TSX:KITS) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Kits Eyecare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Kits Eyecare is: No Data: Cannot be evaluated.

Competitive Comparison of Kits Eyecare's Risk Assessment

For the Specialty Retail subindustry, Kits Eyecare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kits Eyecare's Risk Assessment Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Kits Eyecare's Risk Assessment falls into.

Kits Eyecare (TSX:KITS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Kits Eyecare Risk Assessment Related Terms

Thank you for viewing the detailed overview of Kits Eyecare's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Kits Eyecare (TSX:KITS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Kits Eyecare Ltd (TSX:KITS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

KTYCF:USA 0P3:Germany

Address

510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5

Website

https://www.kits.com

Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its own exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban, and Tom Ford, which enables it to offer its customers first class brands and products in eye care.

Kits Eyecare (TSX:KITS) Headlines

No Headlines